{"id":"monorova","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Monorova","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:32:06.742393+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:32:15.849065+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Monorova","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:32:16.713062+00:00"}},"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-27T23:55:46.771Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:32:19.004575+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03474562","phase":"PHASE4","title":"High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2018-04-03","conditions":"ASCVD, Impaired Fasting Glucose, Hypertension","enrollment":100},{"nctId":"NCT03403556","phase":"PHASE4","title":"High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Yuhan Corporation","startDate":"2018-03-27","conditions":"Atherosclerotic Cardiovascular Disease, Type 2 Diabetes","enrollment":140},{"nctId":"NCT03597412","phase":"PHASE4","title":"Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2018-10-17","conditions":"Atherosclerotic Cardiovascular Disease, Type 2 Diabetes Mellitus","enrollment":236},{"nctId":"NCT03494270","phase":"PHASE4","title":"High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2018-03-18","conditions":"ASCVD","enrollment":270},{"nctId":"NCT03217409","phase":"PHASE4","title":"A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2017-08-10","conditions":"Diabetes Mellitus and Hypercholesterolemia","enrollment":85},{"nctId":"NCT03446261","phase":"PHASE4","title":"Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2018-02-23","conditions":"Type 2 Diabetes Mellitus, Hypercholesterolemia","enrollment":140},{"nctId":"NCT02968160","phase":"PHASE4","title":"A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome","status":"TERMINATED","sponsor":"Yuhan Corporation","startDate":"2016-10","conditions":"Metabolic Syndrome","enrollment":55}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"INCORRECT PRODUCT ADMINISTRATION DURATION"},{"count":1,"reaction":"OFF LABEL USE"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Monorova","genericName":"Monorova","companyName":"Yuhan Corporation","companyId":"yuhan-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":2,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:32:19.004575+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}